Healthcare provider profile · identity verified

Christopher Reed Eilersen, MD

Family Practice · OREGON CITY, OR · NPI 1700853652

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	188
Levothyroxine Sodium	Levothyroxine Sodium	515	132
Amlodipine Besylate	Amlodipine Besylate	389	109
Hydrochlorothiazide	Hydrochlorothiazide	354	103
Lisinopril	Lisinopril	350	116
Gabapentin	Gabapentin	299	76
Omeprazole	Omeprazole	269	81
Trazodone Hcl	Trazodone Hcl	268	63
Losartan Potassium	Losartan Potassium	259	77
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	237	45
Metoprolol Succinate	Metoprolol Succinate	215	69
Tamsulosin Hcl	Tamsulosin Hcl	200	60
Metformin Hcl	Metformin Hcl	189	47
Eliquis	Apixaban	184	45
Oxycodone Hcl	Oxycodone Hcl	178	32
Citalopram Hbr	Citalopram Hydrobromide	170	37
Simvastatin	Simvastatin	163	46
Duloxetine Hcl	Duloxetine Hcl	157	38
Donepezil Hcl	Donepezil Hcl	143	28
Bupropion Xl	Bupropion Hcl	142	31
Sertraline Hcl	Sertraline Hcl	142	37
Allopurinol	Allopurinol	139	36
Furosemide	Furosemide	135	43
Januvia	Sitagliptin Phosphate	124	19
Pantoprazole Sodium	Pantoprazole Sodium	123	31
Metoprolol Tartrate	Metoprolol Tartrate	121	32
Escitalopram Oxalate	Escitalopram Oxalate	119	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	31
Valsartan	Valsartan	105	24
Lorazepam	Lorazepam	99	45
Glimepiride	Glimepiride	96	23
Albuterol Sulfate Hfa	Albuterol Sulfate	94	34
Zolpidem Tartrate	Zolpidem Tartrate	90	18
Alprazolam	Alprazolam	88	20
Rosuvastatin Calcium	Rosuvastatin Calcium	88	29
Venlafaxine Hcl Er	Venlafaxine Hcl	78	17
Atenolol	Atenolol	74	23
Fluticasone Propionate	Fluticasone Propionate	74	24
Potassium Chloride	Potassium Chloride	74	22
Fluoxetine Hcl	Fluoxetine Hcl	72	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	suppressed
Aripiprazole	Aripiprazole	66	16
Estradiol	Estradiol	66	17
Tizanidine Hcl	Tizanidine Hcl	66	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	20
Quetiapine Fumarate	Quetiapine Fumarate	65	17
Memantine Hcl	Memantine Hcl	64	16
Carvedilol	Carvedilol	59	20
Mirtazapine	Mirtazapine	58	suppressed
Prednisone	Prednisone	58	31
Diazepam	Diazepam	53	11
Warfarin Sodium	Warfarin Sodium	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	13
Ozempic	Semaglutide	50	12
Morphine Sulfate Er	Morphine Sulfate	49	suppressed
Metformin Hcl Er	Metformin Hcl	48	19
Spironolactone	Spironolactone	47	15
Famotidine	Famotidine	46	17
Montelukast Sodium	Montelukast Sodium	46	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	37
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Cephalexin	Cephalexin	38	18
Naproxen	Naproxen	38	suppressed
Alendronate Sodium	Alendronate Sodium	36	14
Morphine Sulfate	Morphine Sulfate	36	23
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Topiramate	Topiramate	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	15
Propranolol Hcl Er	Propranolol Hcl	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	27
Propranolol Hcl	Propranolol Hcl	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Divalproex Sodium	Divalproex Sodium	32	suppressed
Ramipril	Ramipril	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Jardiance	Empagliflozin	28	suppressed
Magnesium Sulfate	Magnesium Sulfate	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Finasteride	Finasteride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Azithromycin	Azithromycin	21	16
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Hydromorphone Hcl	Hydromorphone Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Glipizide	Glipizide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Glycopyrrolate	Glycopyrrolate	17	suppressed
Humalog Junior Kwikpen	Insulin Lispro	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Methadone Hcl	Methadone Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amiloride Hcl	Amiloride Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Risperidone	Risperidone	12	suppressed
Theophylline Er	Theophylline Anhydrous	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ethosuximide	Ethosuximide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error